Genistein Enhances TRAIL-Mediated Apoptosis Through the Inhibition of XIAP and DcR1 in Colon Carcinoma Cells Treated with 5-Fluorouracil
Colorectal cancer is one of the most common cancers worldwide. However, surgical intervention and chemotherapy provide only limited benefits for the recovery and survival of patients. The anticarcinogenic effect of genistein has attracted attention because epidemiological studies have shown that soy...
Saved in:
Published in | Turkish Journal of Pharmaceutical Sciences Vol. 21; no. 1; pp. 7 - 24 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Turkey
Galenos Yayinevi Tic. Ltd
01.02.2024
Galenos Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Colorectal cancer is one of the most common cancers worldwide. However, surgical intervention and chemotherapy provide only limited benefits for the recovery and survival of patients. The anticarcinogenic effect of genistein has attracted attention because epidemiological studies have shown that soybean consumption is associated with a decrease in the incidence of cancer. There are limited studies on the effects of genistein in colorectal carcinoma cells. We aimed to investigate the cytotoxic, genotoxic, and apoptotic effects of genistein in SW480 and SW620 colon adenocarcinoma cells treated with 5-fluorouracil, the basis of chemotherapy, and the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) ligand, the mediator of apoptosis, both alone and in combination.
Cytotoxicity and genotoxicity were determined by MTT and comet assays, respectively. The apoptotic effects were evaluated by reverse transcription-polymerase chain reaction assay, with the additional use of Annexin V FITC, mitochondrial membrane potential (MMP), caspase 3, 8, and 9 activity, and reactive oxygen species (ROS) assay kits.
According to our findings, genistein, 5-fluorouracil, and TRAIL had synergistic apoptotic effects because of DR5 upregulation, ROS production, and DNA damage, which were mediated by increased caspase-8, and -9 activity and decreased MMP.
The applied combinations of these compounds may contribute to the resistance problem that may occur in treating colorectal cancer, with a decrease in
and
genes. |
---|---|
AbstractList | ObjectivesColorectal cancer is one of the most common cancers worldwide. However, surgical intervention and chemotherapy provide only limited benefits for the recovery and survival of patients. The anticarcinogenic effect of genistein has attracted attention because epidemiological studies have shown that soybean consumption is associated with a decrease in the incidence of cancer. There are limited studies on the effects of genistein in colorectal carcinoma cells. We aimed to investigate the cytotoxic, genotoxic, and apoptotic effects of genistein in SW480 and SW620 colon adenocarcinoma cells treated with 5-fluorouracil, the basis of chemotherapy, and the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) ligand, the mediator of apoptosis, both alone and in combination.Materials and MethodsCytotoxicity and genotoxicity were determined by MTT and comet assays, respectively. The apoptotic effects were evaluated by reverse transcription-polymerase chain reaction assay, with the additional use of Annexin V FITC, mitochondrial membrane potential (MMP), caspase 3, 8, and 9 activity, and reactive oxygen species (ROS) assay kits.ResultsAccording to our findings, genistein, 5-fluorouracil, and TRAIL had synergistic apoptotic effects because of DR5 upregulation, ROS production, and DNA damage, which were mediated by increased caspase-8, and -9 activity and decreased MMP.ConclusionThe applied combinations of these compounds may contribute to the resistance problem that may occur in treating colorectal cancer, with a decrease in DcR1 and XIAP genes. Objectives: Colorectal cancer is one of the most common cancers worldwide. However, surgical intervention and chemotherapy provide only limited benefits for the recovery and survival of patients. The anticarcinogenic effect of genistein has attracted attention because epidemiological studies have shown that soybean consumption is associated with a decrease in the incidence of cancer. There are limited studies on the effects of genistein in colorectal carcinoma cells. We aimed to investigate the cytotoxic, genotoxic, and apoptotic effects of genistein in SW480 and SW620 colon adenocarcinoma cells treated with 5-fluorouracil, the basis of chemotherapy, and the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) ligand, the mediator of apoptosis, both alone and in combination. Materials and Methods: Cytotoxicity and genotoxicity were determined by MTT and comet assays, respectively. The apoptotic effects were evaluated by reverse transcription-polymerase chain reaction assay, with the additional use of Annexin V FITC, mitochondrial membrane potential (MMP), caspase 3, 8, and 9 activity, and reactive oxygen species (ROS) assay kits. Results: According to our findings, genistein, 5-fluorouracil, and TRAIL had synergistic apoptotic effects because of DR5 upregulation, ROS production, and DNA damage, which were mediated by increased caspase-8, and -9 activity and decreased MMP. Conclusion: The applied combinations of these compounds may contribute to the resistance problem that may occur in treating colorectal cancer, with a decrease in DcR1 and XIAP genes. Keywords: Genistein, 5-fluorouracil, TRAIL, apoptosis, colorectal cancer Colorectal cancer is one of the most common cancers worldwide. However, surgical intervention and chemotherapy provide only limited benefits for the recovery and survival of patients. The anticarcinogenic effect of genistein has attracted attention because epidemiological studies have shown that soybean consumption is associated with a decrease in the incidence of cancer. There are limited studies on the effects of genistein in colorectal carcinoma cells. We aimed to investigate the cytotoxic, genotoxic, and apoptotic effects of genistein in SW480 and SW620 colon adenocarcinoma cells treated with 5-fluorouracil, the basis of chemotherapy, and the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) ligand, the mediator of apoptosis, both alone and in combination. Cytotoxicity and genotoxicity were determined by MTT and comet assays, respectively. The apoptotic effects were evaluated by reverse transcription-polymerase chain reaction assay, with the additional use of Annexin V FITC, mitochondrial membrane potential (MMP), caspase 3, 8, and 9 activity, and reactive oxygen species (ROS) assay kits. According to our findings, genistein, 5-fluorouracil, and TRAIL had synergistic apoptotic effects because of DR5 upregulation, ROS production, and DNA damage, which were mediated by increased caspase-8, and -9 activity and decreased MMP. The applied combinations of these compounds may contribute to the resistance problem that may occur in treating colorectal cancer, with a decrease in and genes. |
Audience | Academic |
Author | Ündeğer Bucurgat, Ülkü Aydın Dilsiz, Sevtap Canpınar, Hande Çal Doğan, Tuğbagül |
AuthorAffiliation | 2 Hacettepe University, Faculty of Pharmacy, Deparment of Pharmaceutical Toxicology, İstanbul, Türkiye 1 Turkish Pharmaceuticals and Medical Devices Agency, Ankara, Türkiye 3 Hacettepe University, Faculty of Medicine, Department of Basic Oncology, İstanbul, Türkiye |
AuthorAffiliation_xml | – name: 2 Hacettepe University, Faculty of Pharmacy, Deparment of Pharmaceutical Toxicology, İstanbul, Türkiye – name: 1 Turkish Pharmaceuticals and Medical Devices Agency, Ankara, Türkiye – name: 3 Hacettepe University, Faculty of Medicine, Department of Basic Oncology, İstanbul, Türkiye |
Author_xml | – sequence: 1 givenname: Tuğbagül orcidid: 0000-0002-1476-0233 surname: ÇAL DOĞAN fullname: ÇAL DOĞAN, Tuğbagül – sequence: 2 givenname: Sevtap orcidid: 0000-0002-6368-2745 surname: AYDIN DİLSİZ fullname: AYDIN DİLSİZ, Sevtap – sequence: 3 givenname: Hande orcidid: 0000-0002-8973-6289 surname: CANPINAR fullname: CANPINAR, Hande – sequence: 4 givenname: Ülkü orcidid: 0000-0002-6692-0366 surname: ÜNDEĞER BUCURGAT fullname: ÜNDEĞER BUCURGAT, Ülkü |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38528786$$D View this record in MEDLINE/PubMed |
BookMark | eNptkl9r1TAYxoNM3HHuK2jAG29a87dNr6TUbR44QxkTdhfSND3NaJPatIrfwI9tunMcDkYuAnmf5_fm5X1egxPnnQHgHUYpIzn7ON-PId2r3jgfUoIITTPEGX0BNgQzkWSE5SdggyliCafo7hSch3CPEMIFpblgr8ApFZyIXGQb8OfKOBtmYx28cJ1y2gR4e1Nud8m1aayaTQPL0Y-zDzYWuskv-w7OnYFb19naztY76Ft4ty2_QeUa-FnfYBhhle9jpVKTts4PClam7yNgMg_IX3buIE8u-8VH4qS07d-Al63qgzk_3mfg--XFbfUl2X292lblLtFM8DlhWWbyIk6rEeNaIcprTjhqGFZFVhPVFoVhmGmmBUY1ZzlimGYaE45NQYigZ-DTgTsu9WAabdw8qV6Okx3U9Ft6ZeXTirOd3PufEqNCECF4JHw4Eib_YzFhloMNOs6nnPFLkBRRHHtmOIvS9wfpui1pXesjUq9yWeZCUIEEK6IqfUYVT2MGq-PuWxvfnxjyg0FPPoTJtI_fx0iuEZFrROQxInKNiHyISHS-_X_6R9-_QNC_-Yu7cg |
CitedBy_id | crossref_primary_10_1016_j_fbio_2024_104659 |
Cites_doi | 10.31002/mathlocus.v2i2.1933 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2024 Galenos Yayinevi Tic. Ltd. Copyright 2024 Turk J Pharm Sci, Published by Galenos Publishing House. 2024 |
Copyright_xml | – notice: COPYRIGHT 2024 Galenos Yayinevi Tic. Ltd. – notice: Copyright 2024 Turk J Pharm Sci, Published by Galenos Publishing House. 2024 |
DBID | NPM AAYXX CITATION 7X8 5PM |
DOI | 10.4274/tjps.galenos.2023.60543 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2148-6247 |
EndPage | 24 |
ExternalDocumentID | A788380849 10_4274_tjps_galenos_2023_60543 38528786 |
Genre | Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- 123 2WC 53G 7X7 8FI 8FJ AAKDD ABDBF ABUWG ADBBV AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS BCNDV BENPR BPHCQ BVXVI CCPQU EBD EOJEC ESX FYUFA GJB GROUPED_DOAJ HMCUK IAO IEBAR IHR INH INR ITC MK0 NPM OBODZ OK1 P6G PIMPY PQQKQ PROAC RPM SW3 TR2 TUS UKHRP AAYXX CITATION M~E 7X8 5PM |
ID | FETCH-LOGICAL-c485t-466e79543c045ca035b5250d41a96b2af99e414c4c810b54704136c1251e92283 |
IEDL.DBID | RPM |
ISSN | 1304-530X |
IngestDate | Tue Sep 17 21:29:05 EDT 2024 Fri Jun 28 20:04:46 EDT 2024 Wed Apr 10 18:05:24 EDT 2024 Tue Apr 09 06:06:46 EDT 2024 Fri Aug 23 02:10:28 EDT 2024 Wed Oct 23 09:34:49 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | 5-fluorouracil apoptosis TRAIL colorectal cancer Genistein |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c485t-466e79543c045ca035b5250d41a96b2af99e414c4c810b54704136c1251e92283 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-1476-0233 0000-0002-8973-6289 0000-0002-6692-0366 0000-0002-6368-2745 |
OpenAccessLink | https://doi.org/10.4274/tjps.galenos.2023.60543 |
PMID | 38528786 |
PQID | 3031136616 |
PQPubID | 23479 |
PageCount | 18 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10982885 proquest_miscellaneous_3031136616 gale_infotracmisc_A788380849 gale_infotracacademiconefile_A788380849 crossref_primary_10_4274_tjps_galenos_2023_60543 pubmed_primary_38528786 |
PublicationCentury | 2000 |
PublicationDate | 2024-02-01 |
PublicationDateYYYYMMDD | 2024-02-01 |
PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Turkey |
PublicationPlace_xml | – name: Turkey |
PublicationTitle | Turkish Journal of Pharmaceutical Sciences |
PublicationTitleAlternate | Turk J Pharm Sci |
PublicationYear | 2024 |
Publisher | Galenos Yayinevi Tic. Ltd Galenos Publishing |
Publisher_xml | – name: Galenos Yayinevi Tic. Ltd – name: Galenos Publishing |
References | ref0 |
References_xml | – ident: ref0 doi: 10.31002/mathlocus.v2i2.1933 |
SSID | ssj0001933784 ssib044763569 |
Score | 2.327528 |
Snippet | Colorectal cancer is one of the most common cancers worldwide. However, surgical intervention and chemotherapy provide only limited benefits for the recovery... Objectives: Colorectal cancer is one of the most common cancers worldwide. However, surgical intervention and chemotherapy provide only limited benefits for... ObjectivesColorectal cancer is one of the most common cancers worldwide. However, surgical intervention and chemotherapy provide only limited benefits for the... |
SourceID | pubmedcentral proquest gale crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 7 |
SubjectTerms | Apoptosis Cancer Carcinoma Chemotherapy Epidemiology Ethylenediaminetetraacetic acid Fluorouracil Isoflavones Oncology, Experimental Original Pharmaceutical industry Soybean Tumor necrosis factor |
Title | Genistein Enhances TRAIL-Mediated Apoptosis Through the Inhibition of XIAP and DcR1 in Colon Carcinoma Cells Treated with 5-Fluorouracil |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38528786 https://search.proquest.com/docview/3031136616 https://pubmed.ncbi.nlm.nih.gov/PMC10982885 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b9swECaSdOlS9F23qcECRbpENhVRFDnKjt24qAPDSABvgkjRsAqbMmJ7yNK5P7t3khVbHbtIAB8niXdH3lHH7wj5qoVUoM_Ky7IAHBQ9Z54M59oLdKq5DmUqSxDX8a24uec_ZuHshIj6LEwZtG903nHLVcflizK2cr0y3TpOrDsZ932mwFGQYfeUnEZB0PTROS8x19RhpwV89khW2W0Z98KAzapALw4eWXf7a73p4GTsCkTvvgo6YOBzTK8TyBDcCTxkfbRi_TtvHy1czaDKo1Vq-JK82JuXNK4-4xU5se41uZhU-NSPl_TucNxqc0kv6OSAXP34hvz5bhFI1-aODtwC5WFD76bx6Kc3LjN62IzG62K9LTY5VFQZfihYkHTkFrkug79oMaezUTyhqcvotZn6FIj1gT5cMW2RK1Yp7dvlEgigvQokcSuYht5wuSuA4kNq8uVbcj8c3PVvvH2qBs9wGW49LoSNFIybARPRpCwINf4vzbifKqGv0rlSlvvccCN9pkMeMVg8hUHryipE4HlHzlzh7AdCeSq4BWIZExmXAVPMYGvoKS1MLkGLsJodybpC5EjAk0FmJsjMZM_MBJmZlMxskW9YmKDOAm9Muj96AA9E9KskjqQMJJNctch5oyXommlUf6kZn2AVBqg5W-w2CVgCmB1H-KJF3leC8PR2tSC1iGyIyFMDhPhu1oDkl1DftaR__P-un8hzGAleRZqfk7Ptw85-BkNqq9ugPbOoTZ7FveveEO69we1kCqXj34N2qVN_AbcLH8c |
link.rule.ids | 230,315,733,786,790,891,27955,27956,31753,33778,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nc9owENWk6aG99PuDNm3VmU56iY2MZSMdGRoKLWSYDJly81iyGNyCzMTmkP6C_uzu2jjg3NoLB1ZejPUk7cpPbwn5pEIhYTxLJ0l8SFDUgjkiWCjHV7HiKhCxKEVcJxfh8Ip_mwfzIxLWZ2FK0r5WqWtXa9emy5JbuVnrds0Ta08nfY9JSBRE0L5H7sOA7QTNLJ3zUnVN7vdaIGvviqq-LeNO4LN5RfXikJO1i5-b3MXp2Gao393xXQjxORbY8UUACQUesz5Ys-7O3AdLV5NWebBODR6TH_U_rOgpv9xtoVz9-474478_gifk0S50pb3K_pQcGfuMnE4r7eubMzrbH-XKz-gpne5VsW-ekz9fDYr0mtTSc7tErOV0dtkbjZ1JWS3EJLS3yTZFlqdgqKoHUYhO6cguU1USy2i2oPNRb0pjm9Av-tKj4KwP_uETSyLZbB3TvlmtwAHGwuASt5lp4AxW2ww8Xsc6Xb0gV4PzWX_o7MpAOJqLoHB4GJquhB7REH7qmPmBwnexCfdiGapOvJDScI9rroXHVMC7DBbmUGPkZiSq-7wkxzaz5jWhPA65AWcJCxMufCaZxtZwpTAwcfktwuqOjjaV2kcEWRLCJEKYRDuYRAiTqIRJi3zGLyOcD6DXdbw71gA_iMpaUa8rhC-Y4LJFThotYRzrhvljDakITUh-sybb5hFEGVh5J_TCFnlVQez27mqItohogO-2AcqHNy0AqVJGvIbQm_-_9AN5MJxNxtF4dPH9LXkIT4VXjPYTclxcb807CNgK9b4cnX8BEno80w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXaFCh66b64TVsWKNJLJFEWJVNHw4kbt3FgBA5goAdBpGhYrU0JkXxIv6Cf3RktsZVjLjqI1GjhIzlDPb4h5KsMRAj9ObSSxIMARS6ZJfyltDwZSy59EYtKxHV6EZxd8R8Lf9GwKouGVmmUTG2z3tgmXVXcynyjnJYn5symI5eFECgI38mTpfOQPIJO2x90I3XOK-W1cLfeApH7QNQ5bhm3fI8taroXh7jMKX_nhY1DsslQw7vv2eDmc0yy4wkfggrcar03b90dvfemry61cm-uGj8jv9q3rCkqf-xtKW31944A5P0-w3PytHFh6bCu84I80OYlOZrVGtg3x3S-29JVHNMjOtupY9-8Iv--axTr1amhp2aFmCvo_HI4ObemVdYQndBhnuVlVqRQUGcRouCl0olZpbIimNFsSReT4YzGJqEn6tKlYGwE9uGIqZFMtonpSK_XYAB9YjCJy83Ut8brbQYWr2OVrl-Tq_HpfHRmNekgLMWFX1o8CPQghFZR4IaqmHm-xH-yCXfjMJD9eBmGmrtccSVcJn0-YDBBBwo9OB2iys8bcmAyo98RyuOAazCWsCDhwmMhU1gbrhQaBjCvR1jb2FFeq35EEC0hVCKEStRAJUKoRBVUeuQbnoxwXICWV3GzvQFuiApb0XAghCeY4GGPHHZqQn9WneIvLawiLEISnNHZtojA28AMPIEb9MjbGma3T9fCtEdEB4C3FVBGvFsCsKrkxFsYvb__pZ_J49nJODqfXPz8QJ7AR-E1sf2QHJTXW_0R_LZSfqo66H__dT9T |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genistein+Enhances+TRAIL-Mediated+Apoptosis+Through+the+Inhibition+of+XIAP+and+DcR1+in+Colon+Carcinoma+Cells+Treated+with+5-Fluorouracil&rft.jtitle=Turkish+Journal+of+Pharmaceutical+Sciences&rft.au=Dogan%2C+Tugbagul+Cal&rft.au=Dilsiz%2C+Sevtap+Aydin&rft.au=Canpinar%2C+Hande&rft.au=Bucurgat%2C+Ulku+Undeger&rft.date=2024-02-01&rft.pub=Galenos+Yayinevi+Tic.+Ltd&rft.issn=1304-530X&rft.volume=21&rft.issue=1&rft.spage=7&rft_id=info:doi/10.4274%2Ftjps.galenos.2023.60543&rft.externalDocID=A788380849 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1304-530X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1304-530X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1304-530X&client=summon |